All living organisms contain transfer ribonucleic acids (tRNA) which function as an integral part of the protein synthesizing machinery and play a role in regulation of gene expression. Of all the RNA populations, tRNAs have the most extensive and varied post-transcriptional modifications. During normal and abnormal cellular development, differences occur in the modified nucleotide content of specific tRNAs. Although the biosynthesis of many modified nucleotides entails post-transcriptional modification of precursor tRNAs, the function of most modified nucleotides is unknown.
The specific aim of this proposal is to determine the mechanism by which selected modified nucleotides modulate tRNA function. Our approach is to obtain homogenic tRNAs and compare their kinetics in the various tRNA requiring reactions. Initially, we will use the naturally occurring homogenic mammalian tRNAs we have isolated from various normal and tumor tissues. Concurrently, we will clone the mammalian phenylalanine tRNA genes and develop an in vitro system by which we can transcribe cloned tRNA genes and use these primary transcripts to obtain a series of in vitro processed homogenic tRNAs. We will compare the reaction kinetics of these naturally occurring and in vitro produced homogenic tRNAs using our complete and fractionated mammalian elongator tRNA dependent in vitro protein synthesis systems. We are in a unique position to accomplish these goals because we have extensive experience in isolating and sequencing mammalina tRNAs, in purifying and characterizing enzymes involved in post-transcriptional tRNA modification, in cloning and sequencing eucaryote mitochondrial tRNA genes, and in developing mammalian cytoplasmic elongator tRNA dependent in vitro protein synthesis systems. These studies will deepen our understanding of the mechanism of the mammalian nuclear-cytoplasmic tRNA processing systems and will allow us to determine directly the effect of alterations in a tRNA's modified nucleotide content during normal and abnormal cellular development.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM030400-05
Application #
3278155
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1981-09-01
Project End
1986-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Oklahoma Norman
Department
Type
Schools of Arts and Sciences
DUNS #
848348348
City
Norman
State
OK
Country
United States
Zip Code
73019
Wilson, R K; Roe, B A (1989) Presence of the hypermodified nucleotide N6-(delta 2-isopentenyl)-2-methylthioadenosine prevents codon misreading by Escherichia coli phenylalanyl-transfer RNA. Proc Natl Acad Sci U S A 86:409-13
Khan, A S; Roe, B A (1988) Aminoacylation of synthetic DNAs corresponding to Escherichia coli phenylalanine and lysine tRNAs. Science 241:74-9
Zehner, Z E; Li, Y; Roe, B A et al. (1987) The chicken vimentin gene. Nucleotide sequence, regulatory elements, and comparison to the hamster gene. J Biol Chem 262:8112-20
Clark, A J; Beguinot, L; Ishii, S et al. (1986) Synthesis of epidermal growth factor (EGF) receptor in vitro using SP6 RNA polymerase-transcribed template mRNA. Biochim Biophys Acta 867:244-51
Wilson, R K; Brown, T; Roe, B A (1986) Nucleotide sequence of pheW;a third gene for E. coli tRNAPhe. Nucleic Acids Res 14:5937
Shtivelman, E; Lifshitz, B; Gale, R P et al. (1986) Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47:277-84
Merlino, G T; Ishii, S; Whang-Peng, J et al. (1985) Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol 5:1722-34
Callahan, R; Chiu, I M; Wong, J F et al. (1985) A new class of endogenous human retroviral genomes. Science 228:1208-11
Roe, B A; Ma, D P; Wilson, R K et al. (1985) The complete nucleotide sequence of the Xenopus laevis mitochondrial genome. J Biol Chem 260:9759-74